- Home
- PKST vs ORIC Comparison
PKST vs ORIC Comparison
Compare PKST & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PKST | ORIC |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 780.2M | 861.3M |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PKST | ORIC |
|---|---|---|
| Price | $20.99 | $7.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | ★ $21.00 | $19.73 |
| AVG Volume (30 Days) | 491.8K | ★ 1.6M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.91% | N/A |
| EPS Growth | N/A | ★ 19.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $105,981,000.00 | N/A |
| Revenue This Year | $12.08 | N/A |
| Revenue Next Year | $10.03 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.50 | $7.23 |
| 52 Week High | $21.00 | $14.93 |
Technical Indicators
Market Signals| Indicator | PKST | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 78.34 | 40.33 |
| Support Level | $20.72 | N/A |
| Resistance Level | N/A | $9.13 |
| Average True Range (ATR) | 0.02 | 0.57 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 85.71 | 16.22 |
Price Performance
Historical ComparisonAbout PKST Peakstone Realty Trust
Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.